Literature DB >> 23751830

18F-FDG PET for diagnosis and response assessment for aggressive NK cell leukemia.

Jeong A Park1.   

Abstract

Aggressive natural killer cell leukemia (ANKL) is a rare malignant disorder of mature NK cells characterized by aggressive clinical course and poor outcome. The commonly involved sites are peripheral blood, bone marrow, liver, and spleen, but any organ can show involvement. We report a case of ANKL diagnosed and assessed the clinical response with 18F-FDG PET. Pretreatment and posttreatment FDG PET/CT showed a high correlation with pathologic diagnosis and staging as well as in the follow-up assessment of the clinical response. FDG PET could be a valuable tool enabling comprehensive staging and follow-up of ANKL.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23751830     DOI: 10.1097/RLU.0b013e3182952976

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  (18)F-FDG PET/CT for Detection of Metachronous Hodgkin's Disease in Patients with Myelofibrosis.

Authors:  Thorsten Derlin; Till Sebastian Clauditz
Journal:  Nucl Med Mol Imaging       Date:  2014-11-14

2.  Six cases of aggressive natural killer-cell leukemia in a Chinese population.

Authors:  Qiguo Zhang; Wang Jing; Jian Ouyang; Hui Zeng; Suraj K George; Zhiqiang Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.